Very true, I have noticed that you usually mention the good points as well.
MLC has a lot to offer a stagnant bauxite company, the directors have offered a premium to keep the company viable IMO.
The big question is why the extension to Medcan acquisition? You think Medcan may want more now that they have a new license? Or Medcan want more shares as the sp has dropped? I can't see QBL reneging from the deal.
All IMO.
Shareholders come first!
- Forums
- ASX - By Stock
- CGB
- How the mcl deal works
How the mcl deal works, page-22
-
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)